- Home
- AUGO vs KNSA Comparison
AUGO vs KNSA Comparison
Compare AUGO & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUGO | KNSA |
|---|---|---|
| Founded | 1946 | 2015 |
| Country | United States | United Kingdom |
| Employees | 1462 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.9B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | AUGO | KNSA |
|---|---|---|
| Price | $64.40 | $63.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $67.60 | $60.86 |
| AVG Volume (30 Days) | ★ 1.0M | 950.9K |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.97% | N/A |
| EPS Growth | N/A | ★ 225.00 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $677,564,000.00 |
| Revenue This Year | $91.05 | $37.48 |
| Revenue Next Year | $17.09 | $17.87 |
| P/E Ratio | ★ N/A | $239.00 |
| Revenue Growth | N/A | ★ 60.09 |
| 52 Week Low | $23.55 | $26.27 |
| 52 Week High | $110.32 | $64.81 |
Technical Indicators
Market Signals| Indicator | AUGO | KNSA |
|---|---|---|
| Relative Strength Index (RSI) | 49.54 | 72.76 |
| Support Level | $65.01 | $40.67 |
| Resistance Level | $75.52 | N/A |
| Average True Range (ATR) | 3.70 | 2.39 |
| MACD | 0.92 | 1.09 |
| Stochastic Oscillator | 60.41 | 97.96 |
Price Performance
Historical ComparisonAbout AUGO Aura Minerals Inc.
Aura Minerals Inc is a mid-tier gold and copper production company focused on the development and operation of gold and base metal projects in the Americas. The company's operating segments include: Minosa Mine, Apoena Mine, the Aranzazu Mine, Almas Mine, Borborema Mine and Serra Grande Mine. It derives maximum revenue from Aranzazu Mine. The company's growth projects include: Matupa in Brazil, and Era Dorada in Guatemala. whereas its exploration projects include: Carajas, in Brazil, and Tolda Fria in Colombia.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.